Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,483 | 45,981 | 56,542 | -69,676 | -53,691 |
| Depreciation Amortization | 259 | 173 | 87 | 343 | 258 |
| Accounts payable and accrued liabilities | -3,032 | -3,236 | -1,379 | 1,683 | -353 |
| Other Working Capital | -7,740 | -6,065 | -5,260 | -2,692 | -1,876 |
| Other Operating Activity | 9,431 | 7,398 | 3,420 | 8,039 | 8,414 |
| Operating Cash Flow | $36,401 | $44,251 | $53,410 | $-62,303 | $-47,248 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 24 | 23 | 13 | 94 | 86 |
| Purchase Of Investment | -128,123 | -113,212 | -23,466 | -122,876 | -119,887 |
| Sale Of Investment | 86,083 | 62,583 | 32,000 | 139,750 | 109,000 |
| Investing Cash Flow | $-42,016 | $-50,606 | $8,547 | $16,968 | $-10,801 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50 | -84 | 32 | 25,547 | 25,256 |
| Financing Cash Flow | $50 | $-84 | $32 | $25,547 | $25,256 |
| Beginning Cash Position | 37,256 | 37,256 | 37,256 | 57,044 | 57,044 |
| End Cash Position | 31,691 | 30,817 | 99,245 | 37,256 | 24,251 |
| Net Cash Flow | $-5,565 | $-6,439 | $61,989 | $-19,788 | $-32,793 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,401 | 44,251 | 53,410 | -62,303 | -47,248 |
| Free Cash Flow | 36,401 | 44,251 | 53,410 | -62,303 | -47,248 |